Published Date: 09 Mar 2023
Recent studies have shown poor outcomes in infants and children with postnatal development.
Read Full NewsNew data highlight the activity and safety of MRD-guided preemptive azacitidine in patients with myelodysplastic neoplasms or AML who develop MRD positivity.
Researchers examine overall response rates of a HER3-targeting antibody-drug conjugate in pretreated patients with non-small cell lung cancer.
1.
The American College of Physicians updated its recommendations for colorectal cancer screening.
2.
Report provides global picture of wide inequalities in care for women's cancers
3.
Check for eating disorders in bipolar disorder patients.
4.
Getting More Done With Less Blood.
5.
Novel radiotracer identifies biomarker for triple-negative breast cancer
1.
Personalizing Cancer Care: Microbiome Advances, Challenges, and Future Directions
2.
Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment
3.
Seeing the Unseen: Examining Chancroid Through Images
4.
Subarachnoid Hemorrhage: Emerging Insights into Pathophysiology and Future Management
5.
Introduction to Immune Thrombocytopenic Purpura
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part I
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
4.
Navigating the Complexities of Ph Negative ALL - Part VII
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation